Castle Biosciences, Inc. (CSTL) vs Damora Therapeutics, Inc. (DMRA)
A side-by-side comparison of Castle Biosciences, Inc. and Damora Therapeutics, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
CSTL
Castle Biosciences, Inc.
$34.02HealthcareDelayed quote: Oct 6, 2026, 12:25 PM EDT
DMRA
Damora Therapeutics, Inc.
$19.17HealthcareDelayed quote: Oct 6, 2026, 12:25 PM EDT
Total return — CSTL vs DMRA
growth of $100 · dividends reinvested · last 6yCSTL -22.2% (-4.1%/yr)DMRA -94.6% (-38.5%/yr)CSTL compounded faster over this window
Log scale — wide-divergence pair
CSTL DMRA
CSTL vs DMRA: by the numbers
- •DMRA is the larger company ($1.18B vs $1.04B market cap).
- •Both run net losses; DMRA's is the smaller (0.00% vs -5.43% net margin).
Metrics side by side
Valuation
| Metric | CSTL | DMRA |
|---|---|---|
| P/S ratio | 2.91 | N/A |
| P/B ratio | 2.21 | 3.06 |
Profitability
| Metric | CSTL | DMRA |
|---|---|---|
| Gross margin | 77.26% | 0.00% |
| Operating margin | -8.99% | 0.00% |
| Net margin | -5.43% | 0.00% |
| ROE | -4.13% | -50.93% |
| ROIC | -6.33% | -52.44% |
Growth (annualized)
| Metric | CSTL | DMRA |
|---|---|---|
| Revenue CAGR (5Y) | 35.55% | N/A |
| Total return CAGR (5Y) | -10.28% | -25.05% |
Frequently asked
- How have CSTL and DMRA total returns compared?
- Over the past 5 years, CSTL delivered -10.28% and DMRA delivered -25.05% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Castle Biosciences ROEDamora Therapeutics ROECastle Biosciences operating marginDamora Therapeutics operating marginCastle Biosciences revenue growthDamora Therapeutics revenue growthCastle Biosciences free cash flowDamora Therapeutics free cash flow
Castle Biosciences & Damora Therapeutics appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.